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Abstract  
Objective: QLQ-C30 and FACT-G are widely-used cancer-specific health-related quality of life 
(HRQOL) questionnaires. We aimed to compare their responsiveness to clinically important 
effects and statistical efficiency to detect such effects.  
Study design and setting: Secondary analysis of QLQ-C30 and FACT-G data from a randomised 
controlled trial of Medical Qigong (n=162 heterogeneous cancer patients). Difference in 
responsiveness (DR) and relative efficiency (RE) were calculated for five domains.  
Results: FACT-G total score was more efficient than QLQ-C30 global scale for detecting change 
within the intervention arm (RE=0.31 (0.083, 0.69)) and comparing change between trials arms 
(RE=0.17 (0.009, 0.58)). In the social domain, the QLQ-C30 scale was more responsive 
(DR=0.28 (0.024, 0.54)) and more efficient within arm only (RE=5.25 (1.21, 232.26)). In the 
physical, functional/role and emotional domains, neither questionnaire was more responsive or 
efficient. 
Conclusion: FACT-G would require about one third the sample of QLQ-C30 to detect a given 
change in overall HRQOL, while in the social domain it would require five times the sample 
size. FACT-G won advantage in overall HRQOL by reduced “noise” (smaller standard deviation 
achieved by summing across 27 items), while QLQ-C30 won advantage in the social domain via 
a larger “signal” (achieved through well-targeted item content). 
 
What is new?  
• As a measure of overall health-related quality of life (HRQOL), the FACT-G total score is 
more responsive to change over time than the QLQ-C30 global scale, and has greater 
statistical efficiency and hence power, for both change within a group and for comparing 
change between two groups.  
• In the social domain, the QLQ-C30 scale is more responsive than the FACT-G scale, and has 
greater statistical efficiency and hence power for the within-group change but not for 
comparing change between two groups.  
• A randomised trial which used the QLQ-C30 to assess overall HRQOL would require a 
sample size approximately five times greater than one which used the FACT-G to detect a 
given difference between trial arms as statistically significant. FACT-G would require about 
one third the sample of QLQ-C30 to detect a given change in overall HRQOL, while in the 
social domain it would require five times the sample size. 
• In the physical, emotional and role/functional domains, the FACT-G and QLQ-C30 have 
similar responsiveness, statistical efficiency and hence power and sample size requirements. 
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• These results should be included along with other relevant considerations to determine the 
optimal patient-reported outcome measure when planning clinical research in cancer.  
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Introduction 
Various criteria come into play when choosing among candidate health-related quality of life 
(HRQOL) questionnaires (1). When choosing a HRQOL questionnaire to evaluate the 
effectiveness of an intervention, responsiveness to a clinically important effect is a key criterion 
(2). The more responsive the measure, the smaller the sample size required to detect a given 
effect (3) or the greater the power for a fixed sample size (4). Little information is currently 
available on the relative responsiveness of different HRQOL measures to guide researchers in 
their choice of such measures.  
When selecting a HRQOL questionnaire for a cancer clinical trial, the European Organisation for 
the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-
C30) (5) and Functional Assessment of Cancer Therapy - General (FACT-G) (6) are often 
obvious candidates (7). There is a large body of evidence supporting the validity and utility of 
each across a wide range of clinical research contexts, and both are available in many languages. 
Lucket et al (2011) provide a thorough comparison of the two measures, highlighting important 
differences in scale structure, social domains and tone that may inform choice for any particular 
study (7). Luckett et al concluded that available psychometric evidence does not recommend one 
questionnaire over the other. Their review highlights the limitations of available evidence about 
responsiveness, in particular that there are no head-to-head comparisons. The value of a head-to-
head comparison is that it allows estimation of both the difference in responsiveness (4) and the 
relative statistical efficiency (3) of two measures. The latter is particularly useful as it estimates 
the factor by which sample size may be reduced if the more responsive measure was used.  
Our aim was to compare the responsiveness, statistical efficiency and power of comparable 
scales from the EORTC QLQ-C30 and the FACT-G, and to quantify the sample size 
implications. 
Methods 
Data set  
We conducted secondary analysis of data from a randomised trial of Medical Qigong (breathing 
and movement exercises). Details of the trial methods and results are reported elsewhere (8). In 
summary, the primary hypothesis of the trial was that patients randomised to Medical Qigong 
(intervention) would experience significant improvements in HRQOL compared with patients 
randomised to usual medical care (control). The Medical Qigong program ran for 10 weeks with 
two group-based supervised 90-minute sessions per week. Participants assigned to the usual care 
arm received usual medical care. Participants were 162 patients with mixed cancer diagnoses at 
variable stages of disease and treatment; n=79 Medical Qigong, n=83 usual care. The FACT-G 
(Version 4) total score was used as the a priori primary outcome measure; QLQ-C30 (Version 3) 
was included to assess responsiveness relative to FACT-G (note: the decision to include the QLQ 
was made mid-study).  HRQOL was assessed prior to randomization (‘pre’) and 10 weeks later 
(‘post’). The original trial analysis showed that participants in the Medical Qigong arm reported 
larger improvements in HRQOL as measured by the FACT-G than those in the usual care arm at 
10-week follow-up (P < 0.001). Statistically significant benefits were also observed for all 
domains of HRQOL [physical, social, emotional and functional well-being, p < 0.001 for each]. 
HRQOL domains and scoring 
In the current analysis, we focus on domains that are common to both the QLQ-C30 and FACT-
G. Both questionnaires cover the four core domains of HRQOL: physical, functional/role, 
emotional, social. The wording and response scales of the items in these domains are shown in 
Table 1, as these may have a bearing on responsiveness and statistical efficiency. The QLQ-C30 
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has a global HRQOL scale (component items shown in Table 1), while the total score of the 
FACT-G is used as a composite measure of HRQOL.  As per standard EORTC scoring 
algorithms, QLQ-C30 domain scores were calculated as the average response across component 
items, transformed linearly to a scale ranging from 0 to 100 (5).  The standard FACT-G scoring 
algorithm is simply to sum responses of component items, after reversing selected items such 
that higher score represents better HRQOL for all (6). Further to this, we transformed these 
linearly to a 0-100 scale to facilitate comparison of mean changes between comparable domains 
of the QLQ-C30 and FACT-G.  For both questionnaires, higher values represent better 
functioning, health and quality of life.   
Statistical Methods 
Responsiveness, power and relative efficiency 
Responsiveness, difference in responsiveness and power were calculated following the methods 
of Tuley (4), and relative statistical efficiency was calculated following the method of Liang et al 
(3), in order to compare the QLQ-C30 with the FACT-G in each of four domains (physical, 
functional/role, emotional, social) and the QLQ-C30 global health /QoL scale with the FACT-G 
total scale.  
A responsiveness index (RI) was calculated as the mean change in the intervention arm divided 
by the standard deviation of change in the control arm. The mean difference in RI between 
comparable QLQ-C30 and FACT-G scales was then calculated, with 95% confidence intervals. 
The null value for difference in responsiveness is 0. 
Relative efficiency was calculated as the squared ratio of t-statistics, (tQLQ/tFACT)2.  Here, tQLQ is 
the t-statistic computed for a t-test using QLQ-C30 data, and tFACT is the corresponding t-statistic 
for the FACT-G data. Two sets of relative efficiency (RE) statistics were calculated. The first 
assessed RE for change within trial arm; REwithin was based on a paired t-test (post-pre), using 
data from the intervention arm only. The second assessed RE for between group difference in 
change within group; REbetween was based in a two sample t-test of the comparison of the pre-post 
difference in intervention versus usual care.  For each RE estimate, bias-corrected accelerated 
95% confidence intervals were generated with 1,000 bootstraps using SAS macros %boot and 
%bootci (9). The null value for RE is 1. 
Missing data and imputation 
Approximately 50% of the data were complete, with about 25% of patients having pre-
intervention scores only. About 15% of patients had FACT-G scores for both time points but 
QLQ-C30 for the second time point only.  We chose to impute the missing data rather than using 
the complete cases only, because the latter: 1) would reduce the effective sample size thereby 
reducing precision; 2) assumes the data are missing completely at random, which was not 
supported by the patterns of missingness (those who were missing the second assessment had 
poorer HRQOL scores in the first assessment, data not shown); 3) our estimates are likely to be 
less biased than if we had used the complete cases only (10).  Multiple imputation was used. 
Four imputation models were implemented: QLQ-C30 measures by trial arm, and FACT-G 
measures by trial arm (11).  Age and gender were also included in each of the imputation 
models. For each of the four imputation models, 100 multiple imputations were generated using 
the MCMC method in SAS Proc MI (12), then averaged by patient identification number to 
create one complete data set. The imputed dataset was analysed to address our study aims, as 
described above.  
Descriptive statistics 
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The following descriptive statistics were calculated as these relate to scale precision and hence 
statistical efficiency and power: the standard deviation (SD) of domain scores, and the average 
inter-item correlation among items within a domain and Cronbach’s alpha. The latter is a 
measure of scale reliability, or “internal consistency”, and is a function of the number of items 
and the average correlation among those items; alpha increases with the number of items and 
with the degree of correlation among them (13). The degree of correlation between instruments 
within domains was also assessed.  All but two of these statistics were calculated for both 
original data and imputed data to assess comparability; Cronbach’s alpha and inter-item 
correlation could not be calculated for the imputed data as imputation was implemented for 
summated scales, not individual items. Histograms were plotted for the imputed dataset to assess 
the degree of ceiling effects (preponderance of scores at maximum value on scale), as these 
could limit the ability of a scale to register improvement, and hence its responsiveness to 
improvement in HRQOL.  All descriptive statistics were calculated for baseline and post-
intervention data. 
Results 
Descriptive statistics of the HRQOL scales 
Descriptive statistics for baseline data are shown in Table 2; results for the post-intervention data 
were generally similar. In the physical domain, the FACT-G scale had higher inter-item 
correlation, more items and hence higher Cronbach alpha.  In contrast, in the emotional domain, 
the FACT-G scale had lower inter-item correlation, and despite more items, lower Cronbach 
alpha.   In the remaining domains, the effect of lower inter-item correlation in the FACT-G was 
countered by more items, such that Cronbach alpha values were similar between the two 
questionnaires. Estimates of SD and correlations tended to be slightly higher in the original data 
than in the imputed data.  The lowest inter-scale correlation was for the social domain (<0.3) and 
the highest correlation was for the global domain (>0.6). 
Histograms of the baseline imputed data (Figure A, online only) show ceiling effects in the social 
domain for both questionnaires. In the physical, functional and emotional domains, there was a 
slight degree of ceiling effect for both questionnaires. Neither the FACT-G total score or QLQ-
C30 global score had a ceiling effect.  
Responsiveness 
Responsiveness index estimates ranged from 0.22 (FACT-G Social Well-being) to 0.84 (FACT-
G total score) (Table 3).  In the social domain, the QLQ-C30 responsiveness index was 
significantly larger than that of the FACT-G (Figure 1). For the remaining domains, 
responsiveness did not differ significantly.  
Relative efficiency 
The FACT-G total score was more efficient than the QLQ-C30 global scale, with a relative 
efficiency (RE) of 0.31 (95% CI: 0.083, 0.69) for the paired t-test in the intervention arm (Table 
3, Figure 2A) and 0.17 (95% CI: 0.009, 0.58 for the two sample t-test (Table 4, Figure 2B). The 
QLQ-C30 was more efficient for the social domain for the paired t-test but not for the two-
sample t-test.  
Sensitivity analysis 
Some of the RE distributions were quite skewed, as evidenced by their wide confidence intervals 
(note log scale for RE in Figure 2). To see if extreme differences in FACT and QLQ scores were 
driving results, we performed sensitivity analysis by setting to missing all values where the 
absolute value of the difference between the FACT change score and the QLQ change score was 
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more than 50 (there were 11 such observations). We then performed the same multiple 
imputation, bootstrapping and computation of the RE as described above. We found that neither 
the estimate nor the confidence intervals changed substantially, except for the two sample t-test 
case for the physical domain, which changed from 1.63, 95% CI: (0.45,13.17) to 0.88 (0.23, 
3.18). However, both confidence intervals contain 1, so the inference (no evidence of difference 
in efficiency) remains the same. 
Discussion 
We detected differences in responsiveness and statistical efficiency between FACT-G and QLQ-
C30 for two of five pairs of scales.  The FACT-G total score was more efficient than the QLQ-
C30 global scale as a measure of overall HRQOL, for both change within the intervention arm 
(paired t-test) and for comparing change between trials arms (two sample t-test). The estimate of 
relative efficiency for the latter case was 0.17, meaning that a randomised trial which used the 
QLQ-C30 to assess global HRQOL would require a sample size approximately five times greater 
than one which used the FACT-G to detect a given difference as statistically significant. In the 
social domain, the QLQ-C30 scale was more responsive than the FACT-G scale and more 
efficient for the within-group t-test only. Since power and sample size are functions of one 
another, if we need fewer subjects for the same power, it is equivalent to saying that for a set 
sample size, one is more powerful than the other. We can therefore infer power from the relative 
efficiency results. 
Given the conventional interpretation of the squared t ratio that we used to assess relative 
efficiency, our results suggest FACT total score would require about one third of the sample 
required by QLQ global QOL scale to detect a given change within a group. In contrast, FACT 
social wellbeing scale would require about five times the sample size required for QLQ social 
functioning scale. Wide confidence intervals on our estimates of relative efficiency reflect 
considerable uncertainty in the actual size of these differentials.   
Statistical efficiency may not be the only consideration in choosing between these two measures. 
It is paramount that the content of the chosen measure’s scales matches the specific QOL-related 
construct(s) of interest in any particular trial (14). So, for example, if a truly global assessment of 
QOL is required, then the QLQ-C30 global QOL scale would be more appropriate than the 
FACT-G total scale, regardless of the latter’s superior statistical efficiency. This is because the 
latter is not a direct measure of global HRQOL but rather a composite of somewhat disparate 
items, each one either causing or reflecting QOL. Table 1 shows that only one of the 27 FACT-G 
items provides a direct measures of global quality of life: “I am content with my quality of life 
right now” (item FWB7), whereas the two items of the QLQ-C30 global scale directly assess 
“overall quality of life” and “overall health”, allowing each respondent to implicitly define and 
weight the components of QOL and health.  If the social domain of QOL was the primary 
outcome of a psychosocial intervention, then the choice between QLQ-C30 and FACT-G may be 
driven more by the difference in their content (Table 1) than by their relative statistical 
efficiency. Further, if multiple aspects of QOL are all important, then sample size needs to be 
adequate for the least efficient of the target scales within a measure. Thus statistical efficiency is 
only one of a number of considerations both in the choice of measure and the determination of 
sample size. 
What might explain the observed differentials in responsiveness and statistical efficiency? 
Tuley’s responsiveness index and the t-statistic (whether paired or two-sample) are ‘signal-to-
noise’ ratios; in each case, the denominator (‘signal’) reflects the mean change observed on the 
HRQOL scale, and the numerator (‘noise’) reflects variability among individuals in change in 
HRQOL. What might amplify or attenuate the signal, and what might increase or decrease the 
noise? First, consider the content of the items in each scale; the extent to which these issues are 
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likely to change, given the patient population, time period and intervention will have a direct 
bearing on signal. The social scale of the QLQ-C30 addresses interference with family and social 
activities, whereas the social scale of the FACT-G focuses on family and social support (Table 
1).  Patients in the Medical Qigong arm registered, on average, an 11% improvement on the 
QLQ-C30 scale, but less that 4% the FACT-G scale. It is plausible that interventions such as 
Medical Qigong can reduce the interference of cancer and its medical treatment on family and 
social activities, but have less impact on family and social support.   
Second, consider the number of items in a scale. Assuming that the items are drawn from an 
infinitely large pool of items reflecting a common domain, increasing the number of items in a 
scale should increase the scale’s reliability, hence precision, and thereby reduce ‘noise’ (15). 
However, the number of items is only half of the story; the underlying assumption is the other 
half. Cronbach’s alpha is a function of the number of items and the average correlation among 
those items; alpha increases with the number of items in a scale and with the degree of 
correlation among those items (13).  The FACT-G global scale (27 items) had the largest alpha 
(0.90), but only marginally greater than that of the 2-item QLQ-C30 global QOL scale (0.86). In 
the social domain, the 2-item QLQ-C30 scale and the 7-item FACT-G achieved the same alpha 
(0.84). Inspection of the content of Table 1 reveals that within any domain, the FACT-G items 
tend to be a more disparate collection than the QLQ-C30; Table 2 confirms that have lower inter-
item correlations for all but the physical domain. Thus the advantage of more items in FACT-G 
scales is countered by their lower inter-item correlation. Luckett et al anticipated that FACT-G 
subscales should be more responsive than their QLQ-C30 counterparts due to their larger number 
of items (1). In the current analysis, this prediction was born out only for extreme case: the 27-
item FACT-G total score versus the 2-item QLQ-C30 global QOL score, highlighting the 
importance of inter-item correlation. Interestingly, the scale with the lowest alpha (0.70) was the 
QLQ-C30 Physical Functioning scale, which is unique among the scales we studied in being a 
Guttman scale; as Table 1 shows, its items are ranked in order of difficulty so that an individual 
who agrees with a particular item is also likely to agree with items of lower rank-order.  Despite 
this low alpha score, this scale was no less responsive or efficient than the FACT-G Physical 
Wellbeing scale in our analyses. 
Perhaps a more directly relevant indicator of ‘noise’ in the current analysis is the standard 
deviation of change of each scale, as this plays directly into the calculation of both the 
responsiveness index and the t-tests on which relative efficiency is  based.  For the Global 
domain, the SD of the FACT-G scale was about half the size of the SD of the QLQ-C30 scale. 
As both detected about the same ‘signal’ , the greater statistical efficiency of the FACT-G scale 
must be attributed to its smaller ‘noise’.  What led to this smaller SD? As an aggregate of 27 
items, the FACT-G total score has many possible values, and thus a far more finely graded (high 
resolution) scale than the relatively coarse QLQ-C30 Global QOL scale; this may be one 
explanation. Another is that for the QLQ-C30, respondents are required to make a global rating 
on two items (QOL and health), an approach which potentially introduces varying interpretations 
of these items as an additional source of noise.   
The third potential factor in the observed differentials in responsiveness and statistical efficiency 
is ceiling effects, as these can limit the ability of a scale to register improvement, and hence its 
responsiveness to improvement in HRQOL. However, as the degree of ceiling effects was about 
the same in both the social scales, and as the neither of the global scales displayed a ceiling 
effect, this factor was clearly not at play in our results. 
A strength of our analysis is that it is based on data from a randomised trial which demonstrated 
a benefit to HRQOL across all FACT-G domains. Responsiveness index estimates ranged from 
0.22 (FACT-G Social Well-being) to 0.84 (FACT-G total score). Although Tuley’s 
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responsiveness index in not a standard effect size (since the denominator and numerator are from 
intervention and control samples, respectively), the form is similar enough to interpret their sizes 
in a similar way; as ranging from small to large with all but the Social Well-being results being 
moderate to large (16).  This is not surprising, as it is well-established that exercise and yoga 
improve the HRQOL and psychological well-being of people with cancer (17, 18); note that 
many of the studies in these two meta-analyses used FACT-G or QLQ-C30. The Medical Qigong 
RCT (8) therefore provides a suitable dataset for the estimation of responsiveness (19).  
However, our conclusions may not generalise to medical interventions, which may affect other 
aspects of HRQOL, such as disease symptoms or treatment side-effects.  A limitation of our 
dataset is the missing data, particularly for QLQ-C30, which was added to the assessment 
schedule after the trial had begun. We chose to impute missing data in order to maximise 
precision and minimise bias, and used the best available means to do so, multiple imputation. 
Further strengths of our analysis are the calculation of confidence intervals and sensitivity 
analysis. We note that the confidence intervals on our estimates of relative efficiency are very 
wide (note the log scale on Figure 2). In part, this is because relative efficiency is a squared ratio.  
This secondary analysis of data provides the first head-to-head comparison of the responsiveness 
and relative statistical efficiency of the QLQ-C30 and FACT-G. This is valuable information for 
people considering these as candidate measures for assessing HRQOL in a clinical trial. More 
generally, this paper demonstrates the utility of estimating relative efficiency. Results for 
difference in responsiveness (after Tuley) and relative efficiency (after Liang et al) were 
consistent, and given its practical interpretation in terms of sample size implications, the latter is 
probably the most useful. Further, the two-sample version of relative efficiency, based on data 
from a RCT, is likely to be the most informative for future RCTs. However, it relies on the use of 
two candidate instruments which measure the same thing (head-to-head comparison), which is 
rarely done in an RCT, due to cost and patient-burden.  Thus, while replication of the analyses in 
this paper for a range of interventions and patient populations would be interesting and valuable, 
it may not be feasible. 
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 Figure 1  Difference in responsiveness index (95% confidence intervals) of comparable scales of FACT-
G and QLQ-C30 
  
 
 
Figure 2  Relative efficiency (95% confidence intervals) of comparable scales of FACT-G and QLQ-
C30, based on the paired t-test (assessing change within the Medical Qigong arm, Panel A) and the two-
sample t-test (comparing change in the intervention arm with change in the control arm, Panel B) 
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